Skip to main content
. Author manuscript; available in PMC: 2017 May 10.
Published in final edited form as: Cell Rep. 2016 Apr 28;15(6):1202–1213. doi: 10.1016/j.celrep.2016.04.007

Figure 5. Blocking PNAd Reduces Targeted Delivery of MP-MECA79 in a Transplant Mouse Model.

Figure 5

(A) FACS analysis of cell suspension from the inguinal DLNs of skin transplant recipients injected with either MP-Rhd-MECA79 or MP-Rhd, showing a greater accumulation of rhodamine-labeled MP-MECA79 compared with MPs.

(B) FACS analysis of cell suspension from the DLNs of skin transplant recipients injected with blocking anti-PNAd antibody 1 hr before injection of rhodamine-labeled particles.

(C) The absolute number of rhodamine-labeled particles in the four different groups of mice (n = 4 mice /group, *p < 0.05).